Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer.

Clinical trial NCT06888648 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06888648
Sponsor: Zhejiang University
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer Metastatic Pancreatic Cancer Non-resectable

Start date: 2025-04-01
Primary completion: 2027-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.